ORIC Pharmaceuticals, Inc. (ORIC)
ORIC Stock Price Chart
Explore ORIC Pharmaceuticals, Inc. interactive price chart. Choose custom timeframes to analyze ORIC price movements and trends.
ORIC Company Profile
Discover essential business fundamentals and corporate details for ORIC Pharmaceuticals, Inc. (ORIC) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
24 Apr 2020
Employees
122.00
Website
https://www.oricpharma.comCEO
Jacob Chacko
Description
ORIC Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical firm dedicated to discovering and advancing innovative treatments for cancer patients across the United States. The company's pipeline includes several key clinical-stage drug candidates. ORIC-533 is an oral small molecule designed to inhibit CD73, addressing resistance to both chemotherapy and immunotherapy. Another candidate, ORIC-944, is an allosteric inhibitor targeting the polycomb repressive complex 2, specifically for the treatment of prostate cancer. Furthermore, ORIC-114 is a brain-penetrant, orally administered, irreversible inhibitor crafted to precisely target epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER2), demonstrating high potency against exon 20 insertion mutations. Beyond these advanced programs, ORIC Pharmaceuticals is also cultivating multiple early-stage precision medicines aimed at other mechanisms of cancer resistance. The company has established partnerships, including a licensing and collaboration agreement with Voronoi Inc., and a licensing agreement with Mirati Therapeutics, Inc. ORIC Pharmaceuticals was founded in 2014 and maintains its headquarters in South San Francisco, California.
ORIC Financial Timeline
Browse a chronological timeline of ORIC Pharmaceuticals, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 11 Aug 2026
EPS estimate is -$0.36.
Earnings released on 4 May 2026
EPS came in at -$0.34 falling short of the estimated -$0.32 by -6.00%.
Earnings released on 23 Feb 2026
EPS came in at -$0.30 surpassing the estimated -$0.34 by +11.76%.
Earnings released on 13 Nov 2025
EPS came in at -$0.33 surpassing the estimated -$0.41 by +19.51%.
Earnings released on 12 Aug 2025
EPS came in at -$0.47 falling short of the estimated -$0.46 by -2.17%.
Earnings released on 5 May 2025
EPS came in at -$0.42 surpassing the estimated -$0.51 by +17.65%.
Earnings released on 18 Feb 2025
EPS came in at -$0.51 surpassing the estimated -$0.52 by +1.92%, while revenue for the quarter reached $533.00k .
Earnings released on 12 Nov 2024
EPS came in at -$0.49 falling short of the estimated -$0.48 by -2.08%.
Earnings released on 12 Aug 2024
EPS came in at -$0.45 falling short of the estimated -$0.42 by -7.14%.
Earnings released on 6 May 2024
EPS came in at -$0.37 surpassing the estimated -$0.44 by +15.91%.
Earnings released on 11 Mar 2024
EPS came in at -$0.49 matching the estimated -$0.49, while revenue for the quarter reached $1.54m .
Earnings released on 6 Nov 2023
EPS came in at -$0.44 surpassing the estimated -$0.46 by +4.35%.
Earnings released on 10 Aug 2023
EPS came in at -$0.50 surpassing the estimated -$0.58 by +13.79%.
Earnings released on 8 May 2023
EPS came in at -$0.53 surpassing the estimated -$0.54 by +1.85%.
Earnings released on 16 Mar 2023
EPS came in at -$0.52 surpassing the estimated -$0.56 by +7.14%.
Earnings released on 7 Nov 2022
EPS came in at -$0.63 falling short of the estimated -$0.55 by -14.55%.
Earnings released on 11 Aug 2022
EPS came in at -$0.51 surpassing the estimated -$0.60 by +15.00%.
Earnings released on 9 May 2022
EPS came in at -$0.59 falling short of the estimated -$0.57 by -3.51%.
Earnings released on 21 Mar 2022
EPS came in at -$0.58 surpassing the estimated -$0.61 by +4.92%.
Earnings released on 8 Nov 2021
EPS came in at -$0.47 surpassing the estimated -$0.58 by +18.97%.
Earnings released on 10 Aug 2021
EPS came in at -$0.57 falling short of the estimated -$0.50 by -14.00%.
ORIC Stock Performance
Access detailed ORIC performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
